Cargando…

Nirmatrelvir and ritonavir for COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081944/
https://www.ncbi.nlm.nih.gov/pubmed/35592371
http://dx.doi.org/10.18773/austprescr.2022.015
_version_ 1784703103322292224
collection PubMed
description
format Online
Article
Text
id pubmed-9081944
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-90819442022-05-18 Nirmatrelvir and ritonavir for COVID-19 Aust Prescr New Drugs NPS MedicineWise 2022-02-28 2022-04 /pmc/articles/PMC9081944/ /pubmed/35592371 http://dx.doi.org/10.18773/austprescr.2022.015 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Nirmatrelvir and ritonavir for COVID-19
title Nirmatrelvir and ritonavir for COVID-19
title_full Nirmatrelvir and ritonavir for COVID-19
title_fullStr Nirmatrelvir and ritonavir for COVID-19
title_full_unstemmed Nirmatrelvir and ritonavir for COVID-19
title_short Nirmatrelvir and ritonavir for COVID-19
title_sort nirmatrelvir and ritonavir for covid-19
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081944/
https://www.ncbi.nlm.nih.gov/pubmed/35592371
http://dx.doi.org/10.18773/austprescr.2022.015